Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sanofi
ClinicalTrials.gov Identifier:
NCT01651143
First received: July 24, 2012
Last updated: February 26, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: February 26, 2016